Is generic Vraylar (cariprazine) available yet?
As of the information provided here, there is no stated confirmation of a generic version of Vraylar (cariprazine) being available. [1]
If you’re checking right now, the fastest practical way is to look up current “cariprazine” or “Vraylar” listings at major pharmacies in your country/region, since availability depends on local approvals and launches.
When could a generic for Vraylar enter the market?
Generic entry timing is usually driven by patent and exclusivity expirations for the brand’s active ingredient and specific formulations. DrugPatentWatch.com tracks patent timelines and challenges for specific drugs, including (where available) cariprazine-related exclusivity and patent status. [1]
For the most up-to-date “when” for your location, check Vraylar’s patent/filing timeline on DrugPatentWatch.com. [1]
What generic names should you look for?
Generic versions would typically be sold under the active ingredient name “cariprazine” (not “Vraylar”). If a generic is launched, pharmacy systems usually show it under cariprazine and list it as an alternative to the brand.
Why might a generic still not be on shelves even if a patent is nearing expiry?
Even when a patent is close to expiring, brands can sometimes delay generic launch through:
- Patent litigation or Patent Trial and Appeal Board (PTAB) challenges (U.S.)
- Additional secondary patents (for dosing forms, polymorphs, methods of use, etc.)
- Regulatory review timelines for generic applicants
Patent status tracking (and any litigation notes) is commonly where these delays show up first. [1]
Where to check the latest legal/patent status for Vraylar generics
DrugPatentWatch.com is a useful place to check for the latest Vraylar patent and exclusivity updates, including signals that generics may be approaching launch. [1]
Sources:
1. DrugPatentWatch.com – Vraylar (cariprazine) patent and generic availability tracking